Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
4.56M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
54.9M
-
Shares change
-
+7.93M
-
Total reported value, excl. options
-
$1.26B
-
Value change
-
+$181M
-
Put/Call ratio
-
0.29
-
Number of buys
-
57
-
Number of sells
-
-18
-
Price
-
$23.01
Significant Holders of RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX) as of Q3 2021
94 filings reported holding RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock as of Q3 2021.
RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.9M shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (22.1M shares), Laurion Capital Management LP (3.92M shares), VANGUARD GROUP INC (2.71M shares), ARK Investment Management LLC (2.59M shares), FMR LLC (1.96M shares), BlackRock Inc. (1.77M shares), STATE STREET CORP (1.64M shares), ALLIANCEBERNSTEIN L.P. (1.64M shares), HARVARD MANAGEMENT CO INC (1.51M shares), and CREDIT SUISSE AG/ (1.45M shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.